Gudin Jeffrey 4
4 · Virpax Pharmaceuticals, Inc. · Filed Apr 9, 2021
Insider Transaction Report
Form 4
Gudin Jeffrey
DirectorChief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-04-07+50,000→ 50,000 totalExercise: $4.62Exp: 2031-04-07→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests in three equal annual installments commencing on April 7, 2022.